Zentek Ltd. (ZEN.V)

2.4100 -0.0300 (-1.23%) At close: 03:59PM EDT

Zentek Ltd.

1205 Amber Drive
Suite 210
Thunder Bay, ON P7B 6M4
Canada
844 730 9822
https://www.zentek.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Francis Dube B.Sc.	Exec. Chairman	181.62k	N/A	N/A
Mr. Gregory Fenton C.F.A.	CEO & Director	137.5k	N/A	N/A
Dr. Colin van der Kuur B.Sc., DMIN	VP of Science & Research	74.89k	N/A	N/A
Ms. Wendy Ford CA, CPA	Chief Financial Officer	N/A	N/A	N/A
Mr. Ryan Shacklock	VP of Strategy, Bus. Devel. & Investor Relations	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite Project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating; and surgical masks, HVAC filters, and personal protective equipment. It is also developing synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is based in Thunder Bay, Canada.

Corporate governance

Zentek Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.